Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Black market versions of Retatrutide are popular among biohackers, even though the drug has not yet been reviewed or approved by the Food and Drug Administration (FDA).
- Simplified Text
-
Black market versions of Retatrutide are popular among biohackers, despite the drug not being reviewed or approved by the FDA.
- Confidence Score
- 0.800
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "date": "2026-09-19" } - Subject Tags
- UUID
- 76f98446-64f0-45fa-8bc2-fffae834cdda
- Vector Index
- ✗ No vector
- Created
- October 2, 2026 at 8:07 AM (1 week ago)
- Last Updated
- October 2, 2026 at 8:07 AM (1 week ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
16
claims
🔥
1 week ago
https://reason.com/2026/09/19/7-cool-advances-in-biosciences
This article explores seven significant advancements in biosciences, including new diabetes and weight loss medications, treatments for high Lp(a), infectious disease vaccines, genome sequencing, cancer vaccines, human reproduction breakthroughs, and anti-aging therapies. It emphasizes the rapid progress in molecular biology.
Similar Claims (5)
Other claims identified as semantically similar to this one.
-
Simplified: Retatrutide, a new diabetes and weight loss medication, is more potent than earlier GLP-1 medications.1 week ago
-
Simplified: A new study identified over 1 million people using weight-loss drugs without a clear medical reason.2 weeks ago
-
Simplified: Off-label prescriptions for GLP-1 drugs increased 15-fold between 2021 and 2025.2 weeks ago
-
Simplified: GLP-1 drugs are approved only for conditions such as obesity and diabetes.2 weeks ago
-
Simplified: Dr. Nils Krüger, a Harvard Medical School researcher who studied GLP-1s, stated that it is the first time he can recall the general public knowing so...2 weeks ago